// App-Quantinova.ai

3222 : Preclinical development of a humanized blocking antibody targeting the CD39 immune checkpoint for cancer immunotherapy

Researchers

Presenter

  • Severine Augier

Principal Investigators

  • Ivan Perrot

  • Cecile Dejou

  • Rachel Joly

  • Stephane Delahaye

  • Helene Rispaud Blanc

  • Caroline Denis

  • Laurent Gauthier

  • Armand Bensussan

  • Jean-francois Eliaou

  • Yannis Morel

  • Nathalie Bonnefoy

  • Jeremy Bastid

  • Carine Paturel

Medical Centers

  • Innate Pharma, Marseille, France

  • Orega Biotech, Ecully, France.

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • 5'-nucleotidase

  • Peripheral blood mononuclear cell

  • Regulatory T cells

Drug/Treatment

  • Adenosine

  • Adenosine Intravenous

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved